Primary |
Product Used For Unknown Indication |
19.4% |
Hypersensitivity |
17.7% |
Drug Use For Unknown Indication |
12.1% |
Multiple Allergies |
8.9% |
Seasonal Allergy |
8.6% |
Ill-defined Disorder |
5.1% |
Rhinitis Allergic |
4.7% |
Hypertension |
3.9% |
Urticaria |
3.3% |
Asthma |
2.8% |
Depression |
2.1% |
Pruritus |
2.1% |
Cough |
1.5% |
Nasopharyngitis |
1.4% |
Sinus Disorder |
1.3% |
Diabetes Mellitus |
1.1% |
Arthritis |
1.0% |
Blood Cholesterol Increased |
1.0% |
Gastrooesophageal Reflux Disease |
1.0% |
Rhinorrhoea |
1.0% |
|
Pruritus |
11.3% |
Wrong Drug Administered |
11.1% |
Withdrawal Syndrome |
10.7% |
Urticaria |
10.1% |
Somnolence |
5.7% |
Pruritus Generalised |
4.9% |
Weight Increased |
4.9% |
Convulsion |
4.5% |
Suicidal Ideation |
4.3% |
Vomiting |
4.1% |
Suicide Attempt |
3.7% |
Off Label Use |
3.5% |
Rash |
3.5% |
Overdose |
3.1% |
Product Quality Issue |
2.7% |
Drug Withdrawal Syndrome |
2.5% |
Electrocardiogram Qt Prolonged |
2.5% |
Pain |
2.5% |
Pyrexia |
2.3% |
Weight Decreased |
2.3% |
|
Secondary |
Product Used For Unknown Indication |
22.3% |
Drug Use For Unknown Indication |
9.3% |
Hypersensitivity |
8.4% |
Seasonal Allergy |
8.4% |
Multiple Allergies |
7.8% |
Hypertension |
5.1% |
Asthma |
4.5% |
Nasopharyngitis |
4.2% |
Cough |
3.8% |
Pyrexia |
3.4% |
Teething |
2.6% |
House Dust Allergy |
2.6% |
Chest Discomfort |
2.5% |
Rhinitis Allergic |
2.5% |
Depression |
2.4% |
Pruritus |
2.4% |
Malaise |
2.2% |
Urticaria |
2.0% |
Rhinorrhoea |
1.9% |
Arthritis |
1.8% |
|
Rash |
9.9% |
Off Label Use |
7.2% |
Urticaria |
6.4% |
Product Quality Issue |
6.2% |
Weight Decreased |
5.7% |
Withdrawal Syndrome |
5.7% |
Wrong Drug Administered |
5.7% |
Transmission Of An Infectious Agent Via A Medicinal Product |
5.2% |
Drug Ineffective |
4.7% |
Throat Irritation |
4.7% |
Vomiting |
4.7% |
Pruritus |
4.4% |
Somnolence |
4.4% |
Memory Impairment |
4.2% |
Overdose |
3.7% |
Suicide Attempt |
3.7% |
Weight Increased |
3.7% |
Suicidal Ideation |
3.5% |
Drug Hypersensitivity |
3.2% |
Headache |
3.2% |
|
Concomitant |
Product Used For Unknown Indication |
27.7% |
Drug Use For Unknown Indication |
13.2% |
Asthma |
9.7% |
Hypersensitivity |
7.3% |
Hypertension |
4.9% |
Pain |
4.3% |
Depression |
3.7% |
Gastrooesophageal Reflux Disease |
3.6% |
Rheumatoid Arthritis |
3.2% |
Multiple Allergies |
2.6% |
Crohn's Disease |
2.5% |
Anxiety |
2.3% |
Contraception |
2.3% |
Seasonal Allergy |
2.2% |
Prophylaxis |
2.0% |
Osteoporosis |
1.9% |
Diabetes Mellitus |
1.8% |
Blood Cholesterol Increased |
1.7% |
Chronic Obstructive Pulmonary Disease |
1.5% |
Premedication |
1.5% |
|
Vomiting |
12.8% |
Weight Increased |
10.0% |
Weight Decreased |
7.1% |
Urticaria |
6.1% |
Pulmonary Embolism |
5.9% |
Nausea |
5.7% |
Pain |
5.5% |
Drug Ineffective |
5.4% |
Rash |
5.1% |
Pruritus |
4.1% |
Wheezing |
3.6% |
Tremor |
3.6% |
Dyspnoea |
3.4% |
Pneumonia |
3.4% |
Sinusitis |
3.4% |
Pain In Extremity |
3.3% |
Urinary Tract Infection |
3.1% |
Vision Blurred |
3.0% |
Headache |
2.9% |
Pyrexia |
2.8% |
|
Interacting |
Product Used For Unknown Indication |
43.9% |
Drug Use For Unknown Indication |
24.4% |
Hypersensitivity |
7.3% |
Depression |
4.9% |
Hypothyroidism |
4.9% |
Application Site Pruritus |
2.4% |
Blood Pressure Increased |
2.4% |
Ear Disorder |
2.4% |
Joint Injury |
2.4% |
Migraine |
2.4% |
Vomiting |
2.4% |
|
Rash |
50.0% |
Urticaria |
20.0% |
Drug Interaction |
10.0% |
Ear Disorder |
10.0% |
Urinary Tract Infection |
10.0% |
|